Adipose-derived stem cells for treatment of chronic ulcers: Current status

Jens Selch Holm*, Navid Mohamadpour Toyserkani, Jens Ahm Sorensen

*Kontaktforfatter for dette arbejde

Publikation: Bidrag til tidsskriftReviewForskningpeer review

125 Downloads (Pure)

Resumé

Chronic ulcers remain a difficult challenge in healthcare systems. While treatment options are limited, stem cells may be a novel alternative. Adipose-derived stem cells (ADSC) have become increasingly popular compared with bone marrow-derived stem cells as they are far easier to harvest. To summarize the current status of treating chronic ulcers with ADSC, this systematic review includes all clinical trials on the subject from PubMed and EmBase, as well as all registered clinical trials on ClinicalTrials.Gov. A total of nine clinical trials and fourteen registered trials were included. The studies were significantly different in terms of study design and patient population, and the overall quality of the studies was low to moderate. Despite the overall low study quality and the significant differences between the studies, some conclusions were consistent: ADSCs are safe, improve the healing of chronic ulcers, and reduce pain. As these results are consistent despite the shortcomings of the studies, they appear to highlight the efficacy of ADSCs in the treatment of chronic ulcers. Larger numbers of higher quality studies are needed to determine the precise role of ADSCs in treating chronic leg ulcers.

OriginalsprogEngelsk
Artikelnummer142
TidsskriftStem Cell Research and Therapy
Vol/bind9
Antal sider11
ISSN1757-6512
DOI
StatusUdgivet - 15. maj 2018

Fingeraftryk

Stem cells
Ulcer
Clinical Trials
Leg Ulcer
PubMed
Bone
Delivery of Health Care
Population

Citer dette

@article{fe309a6933ee4d35b67edc67ee0ea056,
title = "Adipose-derived stem cells for treatment of chronic ulcers: Current status",
abstract = "Chronic ulcers remain a difficult challenge in healthcare systems. While treatment options are limited, stem cells may be a novel alternative. Adipose-derived stem cells (ADSC) have become increasingly popular compared with bone marrow-derived stem cells as they are far easier to harvest. To summarize the current status of treating chronic ulcers with ADSC, this systematic review includes all clinical trials on the subject from PubMed and EmBase, as well as all registered clinical trials on ClinicalTrials.Gov. A total of nine clinical trials and fourteen registered trials were included. The studies were significantly different in terms of study design and patient population, and the overall quality of the studies was low to moderate. Despite the overall low study quality and the significant differences between the studies, some conclusions were consistent: ADSCs are safe, improve the healing of chronic ulcers, and reduce pain. As these results are consistent despite the shortcomings of the studies, they appear to highlight the efficacy of ADSCs in the treatment of chronic ulcers. Larger numbers of higher quality studies are needed to determine the precise role of ADSCs in treating chronic leg ulcers.",
keywords = "Adipose-derived stem cells, Chronic ulcers, Chronic wounds, Stromal vascular fraction, Mesenchymal Stem Cells/physiology, Ulcer/pathology, Humans, Wound Healing, Chronic Disease",
author = "Holm, {Jens Selch} and Toyserkani, {Navid Mohamadpour} and Sorensen, {Jens Ahm}",
year = "2018",
month = "5",
day = "15",
doi = "10.1186/s13287-018-0887-0",
language = "English",
volume = "9",
journal = "Stem Cell Research & Therapy",
issn = "1757-6512",
publisher = "BioMed Central",

}

Adipose-derived stem cells for treatment of chronic ulcers : Current status. / Holm, Jens Selch; Toyserkani, Navid Mohamadpour; Sorensen, Jens Ahm.

I: Stem Cell Research and Therapy, Bind 9, 142, 15.05.2018.

Publikation: Bidrag til tidsskriftReviewForskningpeer review

TY - JOUR

T1 - Adipose-derived stem cells for treatment of chronic ulcers

T2 - Current status

AU - Holm, Jens Selch

AU - Toyserkani, Navid Mohamadpour

AU - Sorensen, Jens Ahm

PY - 2018/5/15

Y1 - 2018/5/15

N2 - Chronic ulcers remain a difficult challenge in healthcare systems. While treatment options are limited, stem cells may be a novel alternative. Adipose-derived stem cells (ADSC) have become increasingly popular compared with bone marrow-derived stem cells as they are far easier to harvest. To summarize the current status of treating chronic ulcers with ADSC, this systematic review includes all clinical trials on the subject from PubMed and EmBase, as well as all registered clinical trials on ClinicalTrials.Gov. A total of nine clinical trials and fourteen registered trials were included. The studies were significantly different in terms of study design and patient population, and the overall quality of the studies was low to moderate. Despite the overall low study quality and the significant differences between the studies, some conclusions were consistent: ADSCs are safe, improve the healing of chronic ulcers, and reduce pain. As these results are consistent despite the shortcomings of the studies, they appear to highlight the efficacy of ADSCs in the treatment of chronic ulcers. Larger numbers of higher quality studies are needed to determine the precise role of ADSCs in treating chronic leg ulcers.

AB - Chronic ulcers remain a difficult challenge in healthcare systems. While treatment options are limited, stem cells may be a novel alternative. Adipose-derived stem cells (ADSC) have become increasingly popular compared with bone marrow-derived stem cells as they are far easier to harvest. To summarize the current status of treating chronic ulcers with ADSC, this systematic review includes all clinical trials on the subject from PubMed and EmBase, as well as all registered clinical trials on ClinicalTrials.Gov. A total of nine clinical trials and fourteen registered trials were included. The studies were significantly different in terms of study design and patient population, and the overall quality of the studies was low to moderate. Despite the overall low study quality and the significant differences between the studies, some conclusions were consistent: ADSCs are safe, improve the healing of chronic ulcers, and reduce pain. As these results are consistent despite the shortcomings of the studies, they appear to highlight the efficacy of ADSCs in the treatment of chronic ulcers. Larger numbers of higher quality studies are needed to determine the precise role of ADSCs in treating chronic leg ulcers.

KW - Adipose-derived stem cells

KW - Chronic ulcers

KW - Chronic wounds

KW - Stromal vascular fraction

KW - Mesenchymal Stem Cells/physiology

KW - Ulcer/pathology

KW - Humans

KW - Wound Healing

KW - Chronic Disease

U2 - 10.1186/s13287-018-0887-0

DO - 10.1186/s13287-018-0887-0

M3 - Review

C2 - 29764508

AN - SCOPUS:85046999669

VL - 9

JO - Stem Cell Research & Therapy

JF - Stem Cell Research & Therapy

SN - 1757-6512

M1 - 142

ER -